A nutritional supplement for human immunodeficiency virus (HIV) antibody positive patients at Mengo Hospital, Kampala, Uganda

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN42274642

Enrollment

350

Registered

2005-08-23

Start date

2005-05-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV antibody positive patients Infections and Infestations Human immunodeficiency virus (HIV)

Interventions

All patients attending the acquired immunodeficiency syndrome (AIDS) clinic at Mengo Hospital will be offered the opportunity to participate. After registration patients will be randomly assigned to 2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Over 18 years 2. CD4 counts 200-500 3. Reside within 15 km of Mengo Hospital at a fixed address

Exclusion criteria

Exclusion criteria: 1. World Health Organisation (WHO) stage 4 disease 2. Pregnant and breast feeding women 3. Patients who have received selenium supplementation in the preceding 3 months 4. Patients currently receiving ARV therapy

Design outcomes

Primary

Measure	Time frame
1. Change in Cd4 counts and GPx 2. Improved quality of life	—

Secondary

Measure	Time frame
1. Delay progression of disease as measured by WHO staging and CD4 counts 2. Delay need to institute ARV therapy	—

Countries

Uganda

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026